UMIN ID: UMIN000001294
Registered date:08/08/2008
Two institutional trial to evaluate the feasibility and efficacy of combined adjuvant therapy with gemcitabine and cisplatin for biliary tract cancer
Basic Information
| Recruitment status | Complete: follow-up complete |
|---|---|
| Health condition(s) or Problem(s) studied | Biriary tract cancer |
| Date of first enrollment | 2008/01/01 |
| Target sample size | 30 |
| Countries of recruitment | Japan |
| Study type | Interventional |
| Intervention(s) | Administration of gemcitabine and cisplatin for adjuvant chemotherapy |
Outcome(s)
| Primary Outcome | Feasibility |
|---|---|
| Secondary Outcome | Efficacy |
Key inclusion & exclusion criteria
| Age minimum | 20years-old |
|---|---|
| Age maximum | 80years-old |
| Gender | Male and Female |
| Include criteria | |
| Exclude criteria | Apparent infection Fever Heart disease Interstitial pneumonia, pulmonary fibrosis Other active cancers Brain metastasis Pericardial effusion Allergy of the drugs Pregnancy or patient's hope to be pregnant |
Related Information
| Primary Sponsor | Chiba Cancer Center |
|---|---|
| Secondary Sponsor | |
| Source(s) of Monetary Support | Self funding |
| Secondary ID(s) |
Contact
| public contact | |
| Name | Osamu Kainuma |
| Address | 666-2 Nitona, Chuo-ku, Chiba, Japan Japan |
| Telephone | 043-264-5431 |
| okainuma@chiba-cc.jp | |
| Affiliation | Chiba Cancer Center Gastroenterological Surgery |
| scientific contact | |
| Name | Takehide Asano |
| Address | 673 Nitona, Chuo-ku, Chiba, Japan Japan |
| Telephone | 043-261-5171 |
| asano@cehpnet.com | |
| Affiliation | National Hospital Organization Chiba-East-Hospital Department of Surgery |